Insilico Medicine � 3CLpro Inhibitor (COVID-19 treatment

This drug is a small molecule inhibitor of 3CLpro, a conserved protease in all known coronaviruses that plays a crucial role in proteolytic processing of the replicase polyproteins. The drug aims to inhibit 3CLpro, blocking SARS-CoV-2 replication and potentially treating multiple strains of COVID-19 and other coronaviruses.